Richard D. Truesdell, Jr.

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $150.4 million follow-on offering of 4,557,774 shares of common stock of…

Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300 million aggregate principal amount of its 3.25% convertible…

Davis Polk is advising Tyson Foods, Inc. on its approximately $4.2 billion acquisition of AdvancePierre Foods Holdings, Inc. The transaction, which is expected to close in the third quarter…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 5,050,505 shares of common stock of…

Davis Polk advised the sole book-running manager in connection with Galapagos NV’s offering of 4,312,500 ordinary shares in the form of American depositary shares, which includes the full…

Davis Polk advised the underwriters in connection with the $352.5 million SEC-registered secondary offering of 23,116,416 shares of Class A common stock of Hostess Brands, Inc. by…

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…

Davis Polk advised Heineken N.V. on its offering of $1.1 billion aggregate principal amount of its 3.50% senior notes due 2028 and $650 million aggregate principal amount of its 4.35%…

Davis Polk advised the representatives of the underwriters in connection with the $75.9 million offering of 3,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…

Davis Polk advised the underwriter in connection with the $182 million SEC-registered secondary offering of 4,109,128 shares of common stock of Financial Engines, Inc. The common stock is…